昭衍新药拟减持股东调整减持计划，拟减持比例降低至不超3%

Group 1 - The core point of the article is that Zhaoyan New Drug (603127) announced a reduction in the shareholding plan of shareholders Gu Xiaolei and Gu Meifang from a maximum of 4.1026% to 3% of the company's total share capital, with the method of reduction changing to a combination of centralized bidding and block trading [1][1][1] - On March 16, Zhaoyan New Drug had previously announced that Gu Xiaolei and his concerted actor Gu Meifang intended to reduce their holdings by up to 4.1026% through centralized bidding, indicating a clearance-style reduction of A-share holdings [1][1][1] - Following this news, Zhaoyan New Drug's stock price hit the daily limit down on March 17 [1][1][1]